Company intelligence / Profile preview

Radence

Ownership: Private
Development stage: Preclinical

Overview

Radence offers advanced research-based precision testing aimed at early disease detection and prevention. The company partners with clinicians to provide personalized health insights before symptoms arise. No clinical trial results are referenced.

Therapeutic areas: OtherInfectious Diseases
Modalities: Precision diagnostics/testingNon-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

Works with clinical collaborators/doctors broadly

Beyond the preview

Go deeper on Radence.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radence.

Explore the full profile